Memorial Sloan Kettering Cancer Center.
University of Arizona.
Clin J Oncol Nurs. 2022 Jul 25;26(4):367-373. doi: 10.1188/22.CJON.367-373.
Patients with cancer are highly vulnerable to COVID-19 because of immunosuppression from diseases and treatments. Emerging data characterize the impact of COVID-19 vaccines related to cancer malignancies and treatments.
This article provides a clinical foundation on the immune response to the COVID-19 vaccine associated with the impact of cancer and its related treatments. It reviews strategies for vaccine scheduling, Centers for Disease Control and Prevention recommendations, and nursing considerations when administering the vaccine to immunosuppressed patients.
Research studies about immune responses to COVID-19 vaccines among immunosuppressed patients with hematologic and solid tumor malignancies were summarized.
Studies about the humoral immune responses of patients with cancer to COVID-19 vaccines help guide vaccination planning for this population. Critical nursing considerations for patients with cancer receiving COVID-19 vaccination are integral to the provision of optimal clinical oncology care during the pandemic.
由于疾病和治疗导致的免疫抑制，癌症患者极易感染 COVID-19。新兴数据描述了 COVID-19 疫苗与癌症恶性肿瘤和治疗相关的影响。
本文提供了与癌症及其相关治疗对 COVID-19 疫苗免疫反应相关的临床基础。本文综述了疫苗接种计划、疾病控制和预防中心推荐方案以及在为免疫抑制患者接种疫苗时的护理注意事项。
总结了关于血液系统恶性肿瘤和实体瘤恶性肿瘤患者对 COVID-19 疫苗免疫反应的研究。
癌症患者对 COVID-19 疫苗的体液免疫反应研究有助于指导该人群的疫苗接种计划。在大流行期间为接受 COVID-19 疫苗接种的癌症患者提供最佳临床肿瘤护理的关键护理注意事项是不可或缺的。
